This website is for UK Healthcare Professionals only

Watch the Clear Horizons TV AD Episode:

Latest updates in care in Atopic Dermatitis

Dr Laura Savage

Consultant Dermatologist at Leeds Teaching Hospitals NHS Trust, with a special interest in Medical Dermatology and Honorary Senior Lecturer, Faculty of Medicine and Health, University of Leeds

Dr Andrew Pink

Consultant Dermatologist and Director of the adult Clinical Trials Unit at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals, London

Dr Sandy McBride

Consultant Dermatologist, Royal Free London NHS Foundation Trust

Professor Richard Warren

Consultant Dermatologist in Manchester, Academic Vice President of the British Association of Dermatologists and Lead for Early Phase trial research across the Northern Care Alliance in Greater Manchester

Dr Amy Foulkes

Consultant Dermatologist at Salford Royal NHS Foundation Trust and an Honorary Senior Clinical Lecturer at the University of Manchester

1. RINVOQ Summary of Product Characteristics

UK-RNQD-210310. Date of preparation: March 2022

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to AbbVie on GBPV@abbvie.com